Equetro Web Pages Omit Risk Info, Make Unsupported Claims On Depression, FDA Says

The agency sent Validus Pharmaceuticals a letter objecting to web pages that minimize the risk of suicidality with use of the bipolar disorder drug and suggest it does not worsen depression or induce weight gain.

Validus Pharmaceuticals LLC is the latest company to be cited by FDA for claims made on its website.

FDA’s Office of Prescription Drug Promotion sent the company an untitled letter saying healthcare professional web pages for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America